Drug Shortage Report for TWYNSTA
| Report ID | 173471 |
| Drug Identification Number | 02371057 |
| Brand name | TWYNSTA |
| Common or Proper name | Twynsta 80/10mg Tablets |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | MARKETED |
| Active Ingredient(s) | AMLODIPINE TELMISARTAN |
| Strength(s) | 10MG 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 4x7 |
| ATC code | C09DB |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-10-31 |
| Actual start date | 2022-10-31 |
| Estimated end date | 2022-11-14 |
| Actual end date | 2022-11-14 |
| Shortage status | Resolved |
| Updated date | 2022-11-16 |
| Company comments | Increased demand due to stock out of generic |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-11-16 | French | Compare |
| v3 | 2022-11-16 | English | Compare |
| v2 | 2022-11-03 | French | Compare |
| v1 | 2022-11-03 | English | Compare |
Showing 1 to 4 of 4